A study in Scientific Reports investigates the association between proton pump inhibitors (PPIs) and histamine-2 receptor antagonists (H2RA) use on chronic kidney disease (CKD) risk.
Study challenges link between proton pump inhibitors and kidney disease risk
- Post author:
- Post published:December 5, 2023
- Post category:uncategorized